Tuesday's announcement comes a little more than a year after Patheon agreed to acquire
, a niche maker of gelatin-based capsules, from
of the Netherlands, for an undisclosed amount. JLL's portfolio of healthcare companies also includes Wakefield, Mass.-based American Dental Partners,
Medical Card Systems Inc.
, of Puerto Rico, and BioClinica, a Newtown, Penn.-based provider of clinical trial management services to pharmaceutical, biotechnology, medical device and contract research organizations worldwide.
The deal is expected to close in the first half of 2014.
DSM, of Heerlen, expects the deal to be accretive to earnings per share from 2014 onwards.
For advice on the deal DSM turned to
Latham & Watkins LLP
, supported by
Cleary Gottlieb Steen & Hamilton LLP
Norton Rose Fulbright Canada LLP
Allen & Overy LLP
Hinckley, Allen & Snyder LLP
Morgan Stanley and Jefferies are serving as financial advisers to JLL Partners. Its legal advisers are
Skadden, Arps, Slate, Meagher & Flom LLP
Borden Ladner Gervais LLP
Simpson Thacher & Bartlett LLP
The independent directors at Patheon used
BMO Capital Markets
as independent valuation expert.
RBC Capital Markets
is the committee's financial adviser and its law firm is
Blake, Cassels & Graydon LLP
-- Written by Renee Cordes in New York